We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$74.2M
(+40%)
Cap. Flow
+$60.4M
Cap. Flow
% of AUM
23.06%
Top 10 Holdings %
Top 10 Hldgs %
27.97%
Holding
236
New
148
Increased
23
Reduced
45
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$8.58M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$7.26M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$5.88M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$4.5M |
| 5 |
Visa
V
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$4.78M |
| 2 |
Novartis
NVS
|
+$4.73M |
| 3 |
Citigroup
C
|
+$3.89M |
| 4 |
Enterprise Products Partners
EPD
|
+$3.74M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$3.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Technology | 18.17% |
| 3 | Financials | 14.51% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Energy | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVYA
76
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $859K | 0.33% |
+42,600
| New | +$941K |
|
77
Moog Inc Class A
MOG.A
$12.5B
| $841K | 0.32% |
10,784
-6,301
| -37% | -$519K |
|
78
Digital Realty Trust
DLR
$64.3B
| $839K | 0.32% |
7,518
+2,846
| +61% | +$302K |
|
79
Philip Morris
PM
$301B
| $807K | 0.31% |
+10,000
| New | +$849K |
|
80
Agios Pharmaceuticals
AGIO
$2.36B
| $799K | 0.31% |
+9,500
| New | +$828K |
|
81
Biogen
BIIB
$30.4B
| $798K | 0.3% |
9,250
+4,546
| +97% | +$1.28M |
|
82
Alphabet (Google) Class A
GOOGL
$4.23T
| $791K | 0.3% |
+14,000
| New | +$761K |
|
83
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $785K | 0.3% |
+20,150
| New | +$778K |
|
84
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
| $775K | 0.3% |
+14,621
| New | +$772K |
|
85
John Wiley & Sons Class A
WLY
$2.59B
| $770K | 0.29% |
12,335
+1,300
| +12% | +$86.3K |
|
86
Fair Isaac
FICO
$29.2B
| $767K | 0.29% |
+3,965
| New | +$718K |
|
87
CACI
CACI
$10.2B
| $766K | 0.29% |
+4,546
| New | +$733K |
|
88
Ubiquiti
UI
$33B
| $762K | 0.29% |
+9,000
| New | +$705K |
|
|
SAGE
89
DELISTED
Sage Therapeutics
SAGE
| $757K | 0.29% |
+4,837
| New | +$759K |
|
90
Invesco Senior Loan ETF
BKLN
$7.19B
| $750K | 0.29% |
+32,757
| New | +$755K |
|
|
SJI
91
DELISTED
South Jersey Industries, Inc.
SJI
| $705K | 0.27% |
21,050
-2,094
| -9% | -$65.7K |
|
92
Realty Income
O
$61.3B
| $662K | 0.25% |
12,695
-7,954
| -39% | -$403K |
|
93
Cencora
COR
$59.9B
| $657K | 0.25% |
+7,700
| New | +$677K |
|
|
FL
94
DELISTED
Foot Locker
FL
| $632K | 0.24% |
+12,000
| New | +$581K |
|
|
MRO
95
DELISTED
Marathon Oil Corporation
MRO
| $630K | 0.24% |
+30,200
| New | +$595K |
|
96
Golar LNG
GLNG
$5.05B
| $618K | 0.24% |
+21,000
| New | +$638K |
|
97
Kimberly-Clark
KMB
$36B
| $618K | 0.24% |
5,867
-3,248
| -36% | -$337K |
|
98
Bausch Health
BHC
$1.8B
| $602K | 0.23% |
+25,917
| New | +$536K |
|
|
AXON
99
Axon Enterprise
AXON
$41.1B
| $600K | 0.23% |
+9,500
| New | +$514K |
|
100
Core Laboratories
CLB
$523M
| $593K | 0.23% |
+4,700
| New | +$572K |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Grace Capital held 236 positions worth $262M, up 40% from $188M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Grace Capital deployed $60.4M of net new capital in Q2 2018, opening 148 new positions and adding to 23 existing holdings. Its largest new stake was MyoKardia, Inc. Common Stock: 177,304 shares worth $8.8M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Citigroup, an estimated $3.89M trimmed.
- Grace Capital's largest Q2 2018 buy was MyoKardia, Inc. Common Stock: 177,304 shares worth $8.8M.
- Grace Capital added most to Meta Platforms (Facebook) in Q2 2018, an estimated $2.91M increase.
- Grace Capital's biggest Q2 2018 reduction was Citigroup, cutting an estimated $3.89M.
- Grace Capital fully exited Check Point Software Technologies in Q2 2018, selling an estimated $4.78M.
- Grace Capital's ten largest holdings make up 28% of its $262M portfolio in Q2 2018.
- Grace Capital opened 148 new positions and closed 16 in Q2 2018.
- Grace Capital's portfolio value rose 40% quarter-over-quarter to $262M.
Based on Grace Capital's 13F filing for Q2 2018, filed 15 Aug 2018.